SCHEMBL18009555

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL19522268	0.86	ACHE (0.51)	ACHEPTGER1PTGER4PTGER3PTGER2
	SCHEMBL18009550	0.86	ACHE (0.51)	ACHEPTGER1PTGER4PTGER3PTGER2
	SCHEMBL19569968	0.85	PTGER1 (0.42)	ACHEPTGER1PTGER4PTGER3PTGER2
	SCHEMBL5952905	0.74	ACHE (0.59)	ACHECYP19A1ELANE
	SCHEMBL19553534	0.74	ACHE (0.58)	ACHEKDM4ECYP19A1ELANE
	SCHEMBL19553603	0.73	ACHE (0.54)	ACHEKDM4EPOLBMAPTCYP19A1
	SCHEMBL18009565	0.73	PTGER1 (0.40)	PTGER1PTGER4PTGER3PTGER2KDM4E
	SCHEMBL5951515	0.71	ACHE (0.55)	ACHEELANE
	SCHEMBL5951331	0.71	ACHE (0.55)	ACHEKDM4EELANE
	SCHEMBL13115609	0.71	ACHE (0.68)	ACHEMAPTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.